
Analyzing Ataxia-telangiectasia-like Disorder 2: The Role of Genetic Testing
Explore the role of genetic testing in diagnosing Ataxia-telangiectasia-like disorder 2 (ATLD2). Early diagnosis, personalized treatment, and genetic counseling.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore the role of genetic testing in diagnosing Ataxia-telangiectasia-like disorder 2 (ATLD2). Early diagnosis, personalized treatment, and genetic counseling.

Unravel atrial conduction disease with genetic testing. Discover its role in diagnosis, personalized treatment, and family planning for optimal cardiac health.

Explore how genetic testing aids in diagnosing Autoimmune Lymphoproliferative Syndrome due to CTLA4 haploinsufficiency, tailoring treatments, and family planning.

Explore how genetic testing aids in diagnosing IFN-gammaR1 deficiency, guiding treatment, and offering predictive insights for managing mycobacterial infections.

Explore the role of ISCU gene variants in autosomal dominant mitochondrial myopathy with exercise intolerance. Learn how genetic testing aids in diagnosis and treatment.

Explore the role of genetic testing in managing Autosomal Dominant Nonsyndromic Hearing Loss 65, enabling early diagnosis, personalized care, and informed family planning.

Explore the role of genetic testing in diagnosing LGMD2U, enabling early diagnosis, personalized treatment plans, and informed family planning for better management.

Explore Autosomal Recessive Nonsyndromic Hearing Loss 102. Uncover how genetic testing and PKHD1L1 gene insights enhance diagnosis, treatment, and family planning.